Elodie Laharanne

776 total citations
22 papers, 494 citations indexed

About

Elodie Laharanne is a scholar working on Pathology and Forensic Medicine, Dermatology and Molecular Biology. According to data from OpenAlex, Elodie Laharanne has authored 22 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Dermatology and 6 papers in Molecular Biology. Recurrent topics in Elodie Laharanne's work include Cutaneous lymphoproliferative disorders research (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Elodie Laharanne is often cited by papers focused on Cutaneous lymphoproliferative disorders research (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Elodie Laharanne collaborates with scholars based in France, Switzerland and Germany. Elodie Laharanne's co-authors include Jean‐Philippe Merlio, M. Beylot‐Barry, B. Vergier, Thomas Jouary, Martina Prochazkova‐Carlotti, Anne Pham‐Ledard, Edith Chevret, Michel Longy, Catherine Gentil and Audrey Gros and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Elodie Laharanne

18 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elodie Laharanne France 12 269 269 158 151 119 22 494
Ana Carolina da Silva Almeida Brazil 8 245 0.9× 191 0.7× 181 1.1× 64 0.4× 189 1.6× 16 529
Farah Abdulla United States 10 146 0.5× 216 0.8× 204 1.3× 109 0.7× 232 1.9× 47 487
Iris Amitay‐Laish Israel 10 93 0.3× 192 0.7× 101 0.6× 89 0.6× 91 0.8× 25 348
Debra Mikkola United States 7 146 0.5× 165 0.6× 94 0.6× 96 0.6× 46 0.4× 10 353
Kayo Tanita Japan 11 68 0.3× 96 0.4× 219 1.4× 47 0.3× 150 1.3× 34 395
Avery Polk United States 7 167 0.6× 67 0.2× 139 0.9× 15 0.1× 160 1.3× 14 313
Gaffey Mj United States 10 147 0.5× 40 0.1× 182 1.2× 33 0.2× 42 0.4× 11 303
Anna Puiggros Spain 9 167 0.6× 48 0.2× 60 0.4× 20 0.1× 131 1.1× 25 345
Claudia Cippitelli Italy 9 128 0.5× 25 0.1× 146 0.9× 31 0.2× 103 0.9× 13 397
Florian Nagl Germany 5 77 0.3× 51 0.2× 102 0.6× 22 0.1× 52 0.4× 6 338

Countries citing papers authored by Elodie Laharanne

Since Specialization
Citations

This map shows the geographic impact of Elodie Laharanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elodie Laharanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elodie Laharanne more than expected).

Fields of papers citing papers by Elodie Laharanne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elodie Laharanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elodie Laharanne. The network helps show where Elodie Laharanne may publish in the future.

Co-authorship network of co-authors of Elodie Laharanne

This figure shows the co-authorship network connecting the top 25 collaborators of Elodie Laharanne. A scholar is included among the top collaborators of Elodie Laharanne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elodie Laharanne. Elodie Laharanne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laharanne, Elodie, Arnaud de la Fouchardière, Audrey Gros, et al.. (2025). Improving diagnostic accuracy in atypical melanocytic tumors using p16 immunohistochemistry and 9p21 fluorescence in situ hybridization: analysis of 206 second opinion cases. Scientific Reports. 15(1). 11425–11425.
2.
Sohier, Pierre, Maxime Battistella, Arnaud de la Fouchardière, et al.. (2025). Comprehensive Molecular Profiling of Cribriform Tumors: Identification of Recurrent 6q/9q Codeletion and CD38 Expression. Modern Pathology. 38(11). 100889–100889.
3.
Cullot, Grégoire, Julian Boutin, David Cappellen, et al.. (2023). Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9. Nature Communications. 14(1). 4072–4072. 16 indexed citations
4.
5.
Prochazkova‐Carlotti, Martina, Audrey Gros, Élodie Richard, et al.. (2022). Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type. Journal of Investigative Dermatology. 143(2). 340–344.e6.
6.
Poglio, Sandrine, Martina Prochazkova‐Carlotti, Audrey Gros, et al.. (2020). Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity. Leukemia. 35(6). 1696–1709. 16 indexed citations
7.
Laharanne, Elodie, Martina Prochazkova‐Carlotti, Audrey Gros, et al.. (2019). Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type. The American Journal of Surgical Pathology. 44(3). 424–427. 2 indexed citations
8.
9.
Gros, Audrey, Elodie Laharanne, Martina Prochazkova‐Carlotti, et al.. (2017). TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma. PLoS ONE. 12(3). e0173171–e0173171. 13 indexed citations
10.
Vergier, B., Elodie Laharanne, Martina Prochazkova‐Carlotti, et al.. (2016). Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood. JAMA Dermatology. 152(10). 1147–1147. 14 indexed citations
11.
Andrique, Laëtitia, Sandrine Poglio, Martina Prochazkova‐Carlotti, et al.. (2016). Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes. Oncotarget. 7(42). 68734–68748. 34 indexed citations
12.
Poglio, Sandrine, Daniel Lewandowski, Julien Calvo, et al.. (2016). Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia. Oncotarget. 7(27). 41599–41611. 8 indexed citations
13.
Bidet, Audrey, et al.. (2016). Analysis of RUNX1 rearrangements: insights into leukaemogenesis mechanisms. British Journal of Haematology. 175(4). 738–740. 2 indexed citations
14.
Caumont, Charline, Rémi Veillon, Audrey Gros, et al.. (2015). Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma. Lung Cancer. 92. 15–18. 41 indexed citations
15.
Chevret, Edith, Laëtitia Andrique, Martina Prochazkova‐Carlotti, et al.. (2014). Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma. Blood. 123(12). 1850–1859. 20 indexed citations
16.
Eimer, Sandrine, Marc‐Antoine Belaud‐Rotureau, Elodie Laharanne, et al.. (2011). Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. Cancer Biology & Therapy. 11(12). 1017–1027. 52 indexed citations
17.
Laharanne, Elodie, Naïma Oumouhou, Françoise Bonnet, et al.. (2010). Genome-Wide Analysis of Cutaneous T-Cell Lymphomas Identifies Three Clinically Relevant Classes. Journal of Investigative Dermatology. 130(6). 1707–1718. 80 indexed citations
18.
Laharanne, Elodie, Edith Chevret, Catherine Gentil, et al.. (2010). CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. Modern Pathology. 23(4). 547–558. 58 indexed citations
19.
Pham‐Ledard, Anne, Martina Prochazkova‐Carlotti, Elodie Laharanne, et al.. (2009). IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases. Journal of Investigative Dermatology. 130(3). 816–825. 88 indexed citations
20.
Marty, Marion, Elodie Laharanne, Edith Chevret, et al.. (2008). Primary Cutaneous T-Cell Lymphomas Do not Show Specific NAV3 Gene Deletion or Translocation. Journal of Investigative Dermatology. 128(10). 2458–2466. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Carolina da Silva Almeida Breakdown of academic impact, for papers by Farah Abdulla Breakdown of academic impact, for papers by Iris Amitay‐Laish Breakdown of academic impact, for papers by Debra Mikkola Breakdown of academic impact, for papers by Kayo Tanita Breakdown of academic impact, for papers by Avery Polk Breakdown of academic impact, for papers by Gaffey Mj Breakdown of academic impact, for papers by Anna Puiggros Breakdown of academic impact, for papers by Claudia Cippitelli Breakdown of academic impact, for papers by Florian Nagl
Rankless by CCL
2026